FCL Pharma SRL
FCL Pharma reported total assets of 895,776 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Aug 2026).
The score of FCL Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +75 % Total assets +9 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
FCL Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 104,960 € | ||||
| Equity | 474,850 € | ||||
| Cash | 52,702 € | ||||
| EBITDA | 148,739 € | ||||
| Total assets | 895,776 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
- Year ended 31 Dec 2022filed on 28 Aug 2023
- Year ended 31 Dec 2021filed on 19 Jul 2022
FCL Pharma's financial analysis
- Solvency53.0%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of FCL Pharma
FCL Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0688.874.501
- VAT number
- BE0688874501
- Peppol
- Registered · 0208:0688874501 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Jan 2018
- Registered office
- 3210 Lubbeek
- Latest accounts
- 2025 · filed on 30 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
FCL Pharma (SRL) has been based in Lubbeek since 2018, active in: activities of holding companies. For 2025, it reports a net profit of 104,960 € and equity of 474,850 €; its revenue is not published. Its solvency stands at 53.0%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to FCL Pharma
Companies in the same business, of comparable size and area, outside its group.
- Swaver Activities of holding companies Nijlen · balance sheet 368,354 €
- Sedes Activities of holding companies Kalmthout · balance sheet 17,961 €
- Derycon Activities of holding companies Knokke-Heist · balance sheet 134,483 €
- International Defence System Support Activities of holding companies Bredene · balance sheet 3,156 €
- KOFFIEGOED België Activities of holding companies Brasschaat · balance sheet 115,342 €
- Artef Activities of holding companies Brasschaat · balance sheet 751 €
- SKS Holding Activities of holding companies Brasschaat · balance sheet 23,272 €
- Yoas Company Activities of holding companies Antwerp · balance sheet 866,171 €
Frequently asked questions about FCL Pharma
What is the revenue of FCL Pharma?
FCL Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of FCL Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0688874501 for FCL Pharma, if the company is VAT-registered. Its company number (CBE) is 0688.874.501.
Where is the registered office of FCL Pharma?
According to the CBE register, the registered office of FCL Pharma is in 3210 Lubbeek.
What is the equity of FCL Pharma?
At the close of the 2025 financial year, the equity of FCL Pharma amounts to 474,850 €, a solvency of 53.0% of total assets.
Who manages FCL Pharma?
The register lists 1 active mandates at FCL Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of FCL Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →